WinstonWınston
Claritev Corporation logo

Claritev Corporation

CTEV
21
Medical - Healthcare Information Services · Healthcare
Winston Score
21
Winston is worried
Weak fundamentals across most pillars.

Claritev Corporation is a healthcare technology company that helps health insurers and other payers manage medical costs. It provides software and data analytics tools that review medical claims — the bills that doctors and hospitals send to insurance companies — to check for errors, flag overcharges, and help negotiate lower payments. The company serves commercial health plans, government programs like Medicaid, and self-insured employers across the United States.

Claritev earns revenue primarily by charging fees based on the volume of claims it processes and the savings it generates for clients, giving it a transaction-based revenue model. It operates mainly in the U.S. and competes in a fragmented market where switching costs and proprietary data networks provide some stickiness with existing clients. With a low operating margin of around 4% and a very low return on invested capital, the key risk is that heavy debt loads from prior acquisitions could limit the company's ability to invest in growth or weather a downturn in healthcare spending.

Winston Score History

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+5.8% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

-0.7% YoY

YoY Growth Rate

Earnings declining

Insider Activity

57.3%ownership

Flat

Insiders holding steady — not selling despite ability to

Cash Runway

~1 months

$21M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Short runway — potential dilution ahead through share issuance

Cash watch

Claritev Corporation has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
26.4%
Modest — 26.4% gross margin
Operating Margin
2.7%
Thin — 2.7% operating margin
ROCE
0.2%
Weak — 0.2% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
+5.5%
Slow sales growth (5.5% YoY)
EPS YoY
N/A
Data not available
EPS Consistency
0/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
N/A
Data not available
FCF Margin
-4.0%
Burning cash (-4.0%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
N/A
Data not available
Interest Cover
0.11x
Dangerous — barely covers interest (0.1x)

Interest coverage below 1. Their profits don't cover the interest bill.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
N/M
no trend
Negative earnings — P/E not meaningful
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial